ROCKVILLE, MD and SHENZHEN, CHINA, Jan 5, 2023 – (ACN Newswire via SEAPRWire.com) – HighTide Therapeutics Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing …
New it.com Domain Name Goes into Sunrise Phase on 2nd January 2023
London, UK, December 30, 2022 – (SEAPRWire) – UK Intis Telecom LTD announces the launch of the new top-level domain name zone (TLD) – it.com. This new …
Mazda: Mid-Term Management Plan Update and Management Policy up to 2030
HIROSHIMA, Japan, Nov 22, 2022 – (JCN Newswire via SEAPRWire.com) – Mazda Motor Corporation today announces an update to its Mid-Term Management Plan and basic …
80-160 year building use rights in IKN to attract investors: Minister
JAKARTA, Oct 12, 2022 – (ACN Newswire via SEAPRWire.com) – The Ministry of Agrarian and Spatial Planning/National Land Agency (ATR/BPN) is offering building use rights …
Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs
SYDNEY, AU, Sep 6, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the …
Zhaoke Ophthalmology Announces 2022 Interim Results
HONG KONG, Aug 24, 2022 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or the “Company”, SEHK: 6622), a leading ophthalmic pharmaceutical …
Nakamoto Games Entering New Growth Phase
Play-to-earn disruptor to finalize private sale token distribution ahead of schedule Mahe, Seychelles, June 25, 2022 – (SEAPRWire) -Nakamoto Games ($NAKA), the token powering the industry’s fastest-growing play-to-earn …
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.
HONG KONG, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock …
Essex Bio-Technology Announces 2021 Financial Results
HONG KONG, Mar 22, 2022 – (ACN Newswire via SEAPRWire.com) – Essex Bio-Technology Ltd (“Essex” or the “Group”, Stock Code: 1061.HK) today announced the annual …
SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE
HONG KONG, Feb 7, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock …
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022
ADELAIDE, AUS, Jan 18, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has …
Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance
HANGZHOU, CHINA, Jan 12, 2022 – (ACN Newswire via SEAPRWire.com) – On January 8, AIM Vaccine held a meeting at Shulan (Hangzhou) Hospital to report …
Investigational Alzheimer’s Disease Therapy Lecanemab Granted FDA Fast Track Designation
TOKYO, Dec 24, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that lecanemab, an investigational anti-amyloid beta (Abeta) …
SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03
HONG KONG, Nov 30, 2021 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab”, or the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical …
Eisai Presents Late-Breaker Updates on Lecanemab Clinical, Biomarker and Safety Data from Phase 2b Study Core and Open-Label Extension
TOKYO, Nov 11, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today results of new clinical, biomarker and safety …
MC and Kinki Sharyo Sign Contract with Egyptian Government for Rolling Stock Deliveries for Phase 1 of Cairo Metro Line 4
TOKYO, Nov 9, 2021 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Corporation (MC) and The Kinki Sharyo Co., Ltd. (Kinki Sharyo) are pleased to announce …
SinoMab, Sinovent and Everest Medicines Announce Licensing Agreement for Global Development and Commercialization of A Next-Generation BTK Inhibitor in Renal Diseases
HONG KONG, Sep 17, 2021 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (HKEX 3681.HK, “SinoMab”) announced with Suzhou Sinovent Pharmaceuticals Co., Ltd. (“Sinovent”) …
Bit2Me Raises 5 Million Euros as Phase One of ICO Sells Out in Under 60 Seconds
MADRID, Sep 7, 2021 – (ACN Newswire via SEAPRWire.com) – Bit2Me has closed the first phase of its ICO (Initial Coin Offering) in just 59 …
Kintor Pharma Announces 2021 Interim Results
SUZHOU, CHINA, Aug 30, 2021 – (ACN Newswire via SEAPRWire.com) – Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small …
Apollomics, Inc. Doses First Patient in Phase I Clinical Trial of APL-102
Foster City, CA, Hangzhou and Shanghai, China, Aug 10, 2021 – (ACN Newswire via SEAPRWire.com) – Apollomics Inc., an innovative biopharmaceutical company committed to the …